Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Annals of Surgery
|
September 17, 2024
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study
Ammar A Javed, Ingmar F Rompen, Iris W J M van Goor, et al.
Annals of Surgery
|
August 12, 2025
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial
Esther N Dekker, Rutger T Theijse, Jacob L van Dam, et al.
BJS Open
|
June 9, 2026
Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection
Thomas F Stoop, Freek R van 't Land, Leonard W F Seelen, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models
Ammar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Journal of the National Cancer Institute
|
September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma
Ammar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
British Journal of Cancer
|
May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology
|
January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
Thomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Annals of Surgery
|
August 6, 2021
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis
Nikolaos Machairas, Dimitri A Raptis, Patricia Sánchez Velázquez, et al.
The British Journal of Surgery
|
June 22, 2026
Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study
Thomas F Stoop, Leonard W F Seelen, Freek R van 't Land, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Annals of Surgery
|
September 17, 2024
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study
Ammar A Javed, Ingmar F Rompen, Iris W J M van Goor, et al.
Annals of Surgery
|
August 12, 2025
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial
Esther N Dekker, Rutger T Theijse, Jacob L van Dam, et al.
BJS Open
|
June 9, 2026
Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection
Thomas F Stoop, Freek R van 't Land, Leonard W F Seelen, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models
Ammar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Journal of the National Cancer Institute
|
September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma
Ammar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
British Journal of Cancer
|
May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
JAMA Oncology
|
January 23, 2025
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX
Thomas F Stoop, Toshitaka Sugawara, Atsushi Oba, et al.
Annals of Surgery
|
August 6, 2021
The Impact of Neoadjuvant Treatment on Survival in Patients Undergoing Pancreatoduodenectomy With Concomitant Portomesenteric Venous Resection: An International Multicenter Analysis
Nikolaos Machairas, Dimitri A Raptis, Patricia Sánchez Velázquez, et al.
The British Journal of Surgery
|
June 22, 2026
Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study
Thomas F Stoop, Leonard W F Seelen, Freek R van 't Land, et al.
Page
of 7